Maria Mironova

Title(s)RESID PHYS/SUBSPEC 4-8/REP, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. International expert panel review for the use of resmetirom and semaglutide in the management of MASH-related fibrosis: clinical practice update. Gut. 2026 Sep 11. Mironova M, Ratziu V, Rinella ME, Bansal MB, Noureddin M, Alkhouri N, Anstee QM, Newsome PN, Schattenberg JM, Sanyal AJ, Loomba R. PMID: 42728029.
      View in: PubMed   Mentions:
    2. Editorial: Clinically Meaningful Cut-Points for ELF in Fibrosis Risk Stratification in MASLD. Aliment Pharmacol Ther. 2026 Aug 24. Mironova M, Loomba R. PMID: 42638176.
      View in: PubMed   Mentions:
    3. Clinical Trial: Phase 3 Trial of Resmetirom Versus Placebo in Metabolic Dysfunction-Associated Steatohepatitis-Reanalysis of Fibrosis Stage 2-3 Subset. Aliment Pharmacol Ther. 2026 Jul 29. Mironova M, Padmanabhan K, Schneider D, Schattenberg JM, Loomba R. PMID: 42527732.
      View in: PubMed   Mentions:    Fields:    
    4. Genotypes of Hepatitis B and D Viruses Among Patients With Hepatitis D in the United States. J Viral Hepat. 2026 Jul; 33(7):e70186. Lopez A, Gopalakrishna H, Chang S, Manhas S, Peinovich N, Richards C, Chee G, Martin R, Mateo R, Mironova M, Swanson BE, Meyer WA, Marlowe EM, Li C, Mo H, Heller T, Maiorova E, Koh C. PMID: 42237932.
      View in: PubMed   Mentions:
    5. Prevalence and Risk Factors Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease and Advanced Fibrosis Among Overweight Individuals: Implications for Screening Guidelines. Am J Gastroenterol. 2026 Jun 24. Mironova M, Tesfai K, Madamba E, Richards L, Bettencourt R, Docherty M, Loomba R. PMID: 42333597.
      View in: PubMed   Mentions:    Fields:    
    6. Clinical Use of Noninvasive Testing for Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease. Clin Gastroenterol Hepatol. 2026 Sep; 24(9):2370-2373. Mironova M, Loomba R. PMID: 42026017.
      View in: PubMed   Mentions:    Fields:    
    7. Serum Proteomics of Insulin Resistance Disorders Distinguish MASLD From Lipodystrophy and Insulin Receptor Defects. J Clin Endocrinol Metab. 2026 Mar 17; 111(4):1057-1065. Mironova M, Wing A, Abel BS, Podszun MC, Brown RJ, Rotman Y. PMID: 41058075; PMCID: PMC13017331.
      View in: PubMed   Mentions:
    8. Exceptionally Long Recurrence-Free Survival in a Male Patient With Fibrolamellar Hepatocellular Carcinoma. Case Reports Hepatol. 2026; 2026:7445319. Townsend EC, Sharma D, Gopalakrishna H, Mironova M, Kleiner DE, Heller T. PMID: 41669374; PMCID: PMC12883663.
      View in: PubMed   Mentions:
    9. Noninvasive Markers Associated With Portal Hypertension and Varices in Patients With Noncirrhotic Portal Hypertension. Clin Transl Gastroenterol. 2026 Feb 01; 17(2):e00956. Gopalakrishna H, Mironova M, Majeed NA, Scott S, Norman-Wheeler J, Koh C, Heller T. PMID: 41410017; PMCID: PMC12922926.
      View in: PubMed   Mentions:
    10. Real World Performance of the Model for End-Stage Liver Disease Score Across Different Races and Ethnicities. Dig Dis Sci. 2026 Feb; 71(2):643-650. Mironova M, Zaiman Z, Samuel MC, Gichoya JW, Holder AL, Celi LA, Stein DJ. PMID: 40900363.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Cardiopulmonary changes and its association with clinical features in noncirrhotic portal hypertension. World J Gastroenterol. 2025 Aug 14; 31(30):109256. Gopalakrishna H, Nguyen ML, Mironova M, Viana Rodriguez GM, Afruza R, Chakraborty M, Menkart MG, Oringher JL, Scott S, Nair GB, Kleiner DE, Koh C, Fallon M, Sachdev V, Heller T. PMID: 40904883; PMCID: PMC12404138.
      View in: PubMed   Mentions:
    12. Asymptomatic Massive Choledocholithiasis in a Patient With Sickle Cell Disease and History of Remote Cholecystectomy. Am J Gastroenterol. 2025 Dec 01; 120(12):2753. Hwang SY, Mironova M, Grecco ML, Heller T. PMID: 40304400.
      View in: PubMed   Mentions:    Fields:    
    13. Immigration Factors and Monitoring of Chronic Hepatitis B Infection Among Foreign-Born: The FOCUS-HBV Multicentre Cohort. Aliment Pharmacol Ther. 2025 Jun; 61(12):1913-1922. Zhou K, Lee A, Wong C, Rangnekar AS, Chen A, Ajokubi J, Keller AI, Smith CI, Hitawala AA, Mironova M, Gopalakrishna H, Norman-Wheeler J, Ghany MG, Dodge JL, Terrault NA, Hsu CC. PMID: 40202373; PMCID: PMC12970947.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Portal sinusoidal vascular diseases: Assessment and therapy. Hepatology. 2025 Apr 04. Mironova M, Gopalakrishna H, Koh C, Kleiner DE, Heller T. PMID: 40194304.
      View in: PubMed   Mentions:
    15. Letter: Prospective evaluation of patients with non-cirrhotic portal hypertension-A single centre study. Authors' reply. Aliment Pharmacol Ther. 2024 Nov; 60(10):1489-1490. Mironova M, Gopalakrishna H, Heller T. PMID: 39329439.
      View in: PubMed   Mentions: 1     Fields:    
    16. Porto-Sinusoidal Vascular Disease in Congenital Erythropoietic Porphyria Needing Liver Transplantation. ACG Case Rep J. 2024 May; 11(5):e01336. Gopalakrishna H, Mironova M, Malik S, Faust A, Khurram N, Koh C, Kleiner DE, Heller T. PMID: 38682079; PMCID: PMC11049708.
      View in: PubMed   Mentions:
    17. Hepatitis B Vaccine: Four Decades on. Vaccines (Basel). 2024 Apr 18; 12(4). Mironova M, Ghany MG. PMID: 38675820; PMCID: PMC11053833.
      View in: PubMed   Mentions:
    18. Prospective evaluation of patients with non-cirrhotic portal hypertension: A single centre study. Aliment Pharmacol Ther. 2024 06; 59(12):1527-1538. Mironova M, Gopalakrishna H, Viana Rodriguez GM, Abdul Majeed N, Hitawala AA, Fuss IJ, Bergerson JRE, Faust AJ, Laurin JM, Norman-Wheeler J, Scott S, Hercun J, Redd B, Kleiner DE, Koh C, Heller T. PMID: 38629442.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    19. Granulomatous liver diseases. Hepatol Commun. 2024 04 01; 8(4). Mironova M, Gopalakrishna H, Rodriguez Franco G, Holland SM, Koh C, Kleiner DE, Heller T. PMID: 38497932; PMCID: PMC10948139.
      View in: PubMed   Mentions:
    20. Meta-analysis: Incidence of cirrhosis and hepatocellular carcinoma in patients with Fontan palliation. Aliment Pharmacol Ther. 2024 May; 59(9):1020-1032. Hitawala AA, Gopalakrishna H, Mironova M, Livinski AA, Wright EC, Downing T, Ito S, Fisher SD, Cedars AM, John AS, Heller T. PMID: 38497159.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    21. Chronic Liver Disease in Patients with Prolidase Deficiency: A Case Series. Case Rep Gastroenterol. 2024 Jan-Dec; 18(1):49-57. Gopalakrishna H, Asif B, Rai A, Conjeevaram HS, Mironova M, Kleiner DE, Freeman AF, Heller T. PMID: 38304571; PMCID: PMC10834036.
      View in: PubMed   Mentions:
    22. Advances and Challenges in Managing Hepatitis D Virus: Evolving Strategies. Curr Hepatol Rep. 2024; 23(1):32-44. Gopalakrishna H, Mironova M, Dahari H, Koh C, Heller T. PMID: 38533303; PMCID: PMC10965034.
      View in: PubMed   Mentions:
    23. Risk of Hepatocellular Carcinoma After Spontaneous Clearance of Hepatitis C Virus and in Noncirrhosis Chronic Hepatitis C Patients With Sustained Virological Response: A Systematic Review. Clin Infect Dis. 2023 08 14; 77(Suppl 3):S245-S256. Hsu CC, Gopalakrishna H, Mironova M, Lee MH, Chen CJ, Yang HI, Wiese M, Chang KM, Wright EC, Abijo T, Feld JJ, Kaplan DE. PMID: 37579210; PMCID: PMC10425144.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    24. Fecal microbiota transplantation may reduce the mortality of patients with severe and fulminant Clostridioides difficile infection compared to standard-of-care antibiotics in a community hospital. J Dig Dis. 2022 Aug; 23(8-9):500-505. Mironova M, Ehrlich AC, Grinspan A, Protano MA. PMID: 36183340.
      View in: PubMed   Mentions:
    Maria's Networks
    Concepts (75)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (9)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-40-gb10dcd06 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California